Skip to playerSkip to main content
  • 9 months ago
CONGRESSMAN CARTER URGING MATTHEW STRAIT DEA TO ADVANCE MARIJUANA CLINICAL RESEARCH

MMJ International Holdings distinguishes itself by adhering strictly to federal regulations at every stage of its R&D process. Rather than cutting corners, the company ensures its FDA clinical trials for its proprietary soft gelatin capsule-blending THC, CBD, and other phytocannabinoids-meet the highest standards set by federal law. This commitment not only minimizes regulatory risks but also enhances MMJ's credibility with government agencies and leading healthcare institutions.

Transcript
00:00We want to do the right thing.
00:04You know, I saw an article just here recently that said that there's actually the use of
00:11new research found opioids were prescribed less often in states where marijuana had been
00:15legalized for medicinal or recreational use.
00:19You know, as a practicing pharmacist for many years, I've always said that the only thing
00:23worse for me than filling a prescription for someone who doesn't need it is not filling
00:28a prescription for someone who does need it.
00:31If marijuana truly does have medicinal benefit, I want to use it.
00:37I am adamantly opposed to the recreational use of it.
00:40I think it is a gateway drug, and it should not be used recreationally.
00:44But if there are benefits to it, I want it to be used.
00:48All we want here, everyone has expressed the same thing throughout this whole hearing.
00:53Tell us how we can get this research done.
00:55Tell us how we can find out.
00:56It is the epitome of ineptitude that the federal government has as scheduled as a schedule
01:02one drug, and 11 states have approved it recreationally.
01:07Embarrassing.

Recommended